| Name | Title | Contact Details |
|---|
The University of Texas, Anderson Cancer Center is a Ann Arbor, MI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
EAR TECHNOLOGY Corp. is a Johnson City, TN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Intersect ENT (Nasdaq:XENT) is a medical technology company dedicated to advancing the treatment of ear, nose and throat (ENT) conditions through evidence-based innovation, providing physicians with solutions to overcome clinical challenges and improve the quality of life for patients.
JenaValve Technology, Inc., based in Irvine, California and Munich, Germany develops, manufactures and markets transcatheter aortic valve implantation (TAVI) systems to treat patients suffering from aortic valve disease. The Company’s transapical TAVI system is CE marked and currently marketed in Europe and other markets worldwide and its new transfemoral TAVI system is currently undergoing clinical evaluation in Europe with a view toward achieving CE Mark in 2015. JenaValve is backed by world-class U.S., European and Asian investors, including Atlas Venture, Edmond de Rothschild Investment Partners, GIMV, NeoMed Management, Legend Capital, VI Partners, Sunstone Capital, Omega Funds, Biovest and Valiance Advisors.
UT Technology Inc. is a Edmonton, AB-based company in the Healthcare, Pharmaceuticals, and Biotech sector.